Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment: protocol for a systematic review and individual participant data meta-analysis. Issue 11 (7th November 2022)

• Record Type: Journal Article
• Authors: Evans-Hoeker, Emily; Wang, Zheng; Groen, Henk; Cantineau, Astrid E P; Thurin‐Kjellberg, Ann; Bergh, Christina; Laven, Joop S E; Dietz de Loos, Alexandra; Jiskoot, Geranne; Baillargeon, Jean-Patrice; Palomba, Stefano; Sim, Kyra; Moran, Lisa J; Espinós, Juan J; Moholdt, Trine; Rothberg, Amy E; Shoupe, Donna; Hoek, Annemieke; Legro, Richard S; Mol, Ben W; Wang, Rui
• Is Part Of: BMJ open. Volume 12:Issue 11(2022)
• Publication Date: 2022-11-07
• Subjects: Subfertility -- NUTRITION & DIETETICS -- SPORTS MEDICINE -- Reproductive medicine -- PERINATOLOGY; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2022-065206
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Dietary and/or physical activity interventions are often recommended for women with overweight or obesity as the first step prior to fertility treatment. However, randomised controlled trials (RCTs) so far have shown inconsistent results. Therefore, we propose this individual participant data meta-analysis (IPDMA) to evaluate the effectiveness and safety of dietary and/or physical activity interventions in women with infertility and overweight or obesity on reproductive, maternal and perinatal outcomes and to explore if there are subgroup(s) of women who benefit from each specific intervention or their combination (treatment–covariate interactions). Methods and analysis: We will include RCTs with dietary and/or physical activity interventions as core interventions prior to fertility treatment in women with infertility and overweight or obesity. The primary outcome will be live birth. We will search MEDLINE, Embase, Cochrane Central Register of Controlled Trials and trial registries to identify eligible studies. We will approach authors of eligible trials to contribute individual participant data (IPD). We will perform risk of bias assessments according to the Risk of Bias 2 tool and a random-effects IPDMA. We will then explore treatment–covariate interactions for important participant-level characteristics. Ethics and dissemination: Formal ethical approval for the project (Venus-IPD) was exempted by the medical ethics committee of the University Medical Center Groningen (METc code: 2021/563, date: 17 November 2021). Data transfer agreement will be obtained from each participating institute/hospital. Outcomes will be disseminated internationally through the collaborative group, conference presentations and peer-reviewed publication. PROSPERO registration number: CRD42021266201.